ConductScience.org, home

Paper42490100

Optic Nerve Alterations Following Intravitreal Injection and Laser in Infants With Retinopathy of Prematurity.

Deng X and 6 others. Invest Ophthalmol Vis Sci, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Optic Nerve Alterations Following Intravitreal Injection and Laser in Infants With Retinopathy of Prematurity. Papers, record 42490100. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42490100

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Optic Nerve Alterations Following Intravitreal Injection and Laser in Infants With Retinopathy of Prematurity.
PubMed
Journal
Invest Ophthalmol Vis Sci
PubMed
Year
2026
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-23
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Deng XXinyi
2Zhang SShian
3Zhang YYanli
4Gao XXinyu
5Shen YYang
6Shen LLijun
7Mao JJianbo

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Retinopathy of PrematurityMajor topic
Laser CoagulationMajor topic
Angiogenesis InhibitorsMajor topic
Optic NerveMajor topic
Humans
Intravitreal Injections
Retrospective Studies
Female
Male
Infant, Newborn
Gestational Age
Vascular Endothelial Growth Factor A
Infant, Premature
Ranibizumab

Source PubMed

Download CSV of topics

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126403327Retinal nerve fiber layer thickness in prematurity is correlated with stage of retinopathy of prematurity.Eye (Lond)2015https://conductscience.org/library/papers/26403327PubMed
24856871Complications of argon laser photocoagulation.Trans Am Acad Ophthalmol Otolaryngol1974https://conductscience.org/library/papers/4856871PubMed
338141904Extending Peripheral Retinal Vascularization in Retinopathy of Prematurity Through Regulation of VEGF Signaling.Am J Ophthalmol2024https://conductscience.org/library/papers/38141904PubMed
437324456Intraocular pressure effect of intravitreal conbercept injection for retinopathy of prematurity.Front Pharmacol2023https://conductscience.org/library/papers/37324456PubMed
528439729Macular morphology in former preterm and full-term infants aged 4 to 10 years.Graefes Arch Clin Exp Ophthalmol2017https://conductscience.org/library/papers/28439729PubMed
632710087VEGF is an autocrine/paracrine neuroprotective factor for injured retinal ganglion neurons.Sci Rep2020https://conductscience.org/library/papers/32710087PubMed
737991127Central macular morphology and optic nerve fibre layer thickness in young adults born premature and screened for retinopathy of prematurity.Acta Ophthalmol2024https://conductscience.org/library/papers/37991127PubMed
87285772Periods of development of the normal human chamber angle.Doc Ophthalmol1981https://conductscience.org/library/papers/7285772PubMed
929241743Glaucoma after Lens-Sparing Vitrectomy for Advanced Retinopathy of Prematurity.Ophthalmology2018https://conductscience.org/library/papers/29241743PubMed
1035615084Intravitreal Anti-vascular Endothelial Growth Factor Injection for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis.Front Med (Lausanne)2022https://conductscience.org/library/papers/35615084PubMed
1133387554Retinal Detachment after Treatment of Retinopathy of Prematurity with Laser versus Intravitreal Anti-Vascular Endothelial Growth Factor.Ophthalmology2021https://conductscience.org/library/papers/33387554PubMed
1230954553Neurodevelopmental Outcomes after Intravitreal Bevacizumab Therapy for Retinopathy of Prematurity: A Prospective Case-Control Study.Ophthalmology2019https://conductscience.org/library/papers/30954553PubMed
1331762784A review of treatment for retinopathy of prematurity.Expert Rev Ophthalmol2019https://conductscience.org/library/papers/31762784PubMed
147904794Improved visual function in retinopathy of prematurity after lowering high intraocular pressure.Am J Ophthalmol1994https://conductscience.org/library/papers/7904794PubMed
1533372558Long-term macular vascular density measured by OCT-A in children with retinopathy of prematurity with and without need of laser treatment.Eur J Ophthalmol2021https://conductscience.org/library/papers/33372558PubMed
1615350330Intraocular pressure variations after diode laser photocoagulation for threshold retinopathy of prematurity.Ophthalmology2004https://conductscience.org/library/papers/15350330PubMed
1736813874Retinal and peripapillary vascular deformations in prematurely born children aged 4-12 years with a history of retinopathy of prematurity.Sci Rep2023https://conductscience.org/library/papers/36813874PubMed
1839524166Recurrence of Retinopathy of Prematurity Following Anti-vascular Endothelial Growth Factor (Anti-VEGF) Therapy: A Systematic Review and Meta-Analysis.Cureus2024https://conductscience.org/library/papers/39524166PubMed
1940613237Effects of anti‑VEGF on peripapillary retinal nerve fiber layer and papillary/peripapillary blood circulation in retinopathies (Review).Int J Mol Med2025https://conductscience.org/library/papers/40613237PubMed
202314833Anterior segment evaluation of infants with retinopathy of prematurity.Ophthalmology1990https://conductscience.org/library/papers/2314833PubMed

See all 29 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42490100

GET https://conductscience.org/api/papers/v1/42490100/references?page=2